Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pandemic Flu Scare Fades, Vaccine Glut Seen for Glaxo,Baxter
Bloomberg
Friday, January 15, 2010 - 8:51am
tags:
vaccines, GSK, H1N1, Baxter International
Merck: My Favorite Dow 30 Stock
Seeking Alpha
Friday, January 15, 2010 - 8:50am
tags:
Merck
Mass. doctor accused of faking painkiller studies charged with federal health care fraud
Yahoo/AP
Friday, January 15, 2010 - 8:48am
tags:
Massachusetts, health care fraud, Vioxx, Merck, Bextra, Pfizer
Lawsuit Challenges Marketing of Stents
NY Times, NY
Friday, January 15, 2010 - 8:47am
tags:
stents, Boston Scientific, JNJ, lawsuits, Guidant
Pfizer Was Also Questioned in EU On Generic Deals
WSJ Online
Thursday, January 14, 2010 - 4:57pm
tags:
Pfizer, Europe, generics, patents
Hemispherx submits new Ampligen data to FDA
Bizjournals.com
Thursday, January 14, 2010 - 4:16pm
tags:
FDA, Ampligen, Hemispherx
Pfizer's Interest in Enzon May Create Jackpot Payday for CEO Buchalter
BNET Pharma
Thursday, January 14, 2010 - 4:13pm
tags:
Pfizer, Enzon, Jeffrey Buchalter
Moody's raises Teva credit rating
Yahoo/AP
Thursday, January 14, 2010 - 4:12pm
tags:
Teva Pharmaceuticals, credit rating
FDA finds no heart risk with Spiriva inhaler
Yahoo/AP
Thursday, January 14, 2010 - 4:10pm
tags:
Spiriva, FDA, Pfizer, Boehringer Ingelheim
That Novartis-Alcon Deal May Have a Tax Problem
WSJ Online
Thursday, January 14, 2010 - 4:09pm
tags:
M&A, Alcon, Novartis
Alnylam Pharma Guides
Yahoo/Zacks.com
Thursday, January 14, 2010 - 10:16am
tags:
Alnylam, guidance, Novartis, Biogen Idec
EnteroMedics, Bionovo: Early Volume Plays
TheStreet.com
Thursday, January 14, 2010 - 10:15am
tags:
Bionovo, EnteroMedics
Somaxon Pharmaceuticals: "Rest in Peace?"
BNET Pharma
Thursday, January 14, 2010 - 9:57am
tags:
Somaxon, Silenor
Here Are Those FDA Warning Letters(Bayer, Lilly, Amylin, Cephalon)
Pharmalot
Thursday, January 14, 2010 - 9:53am
tags:
Bayer, Eli Lilly, Amylin, Cephalon, FDA, warnings
The Merck Rating That Got Everybody So Excited
WSJ Online
Thursday, January 14, 2010 - 9:50am
tags:
Merck, Vytorin, upgrades
Rise of multi-site trials prompts FDA guidance on IRBs
Outsourcing-Pharma
Thursday, January 14, 2010 - 9:41am
tags:
FDA, clinical trials, IRBs
Pfizer Layoffs: Whose Jobs Are Safe, and Whose Aren't?
BNET Pharma
Thursday, January 14, 2010 - 9:18am
tags:
Pfizer, layoffs, Wyeth, M&A, reorganization
Home-Care Mergers Loom for Amedysis, Gentiva on Overhaul Cuts
Bloomberg
Thursday, January 14, 2010 - 9:15am
tags:
home healthcare, Gentiva, Amedisys, M&A
MannKind expects FDA to approve inhaled insulin
Reuters
Thursday, January 14, 2010 - 9:05am
tags:
inhaled insulin, MannKind, FDA, Afresa, Afrezza
Merck Submits Data To Widen Gardasil Use
Pharmalot
Thursday, January 14, 2010 - 9:04am
tags:
Merck, HPV, vaccines, Gardasil

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.